Drug profile · INN
bevacizumab-awwb
MVASI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
bevacizumab-awwb (MVASI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN bevacizumab-awwb
Brand MVASI
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is bevacizumab-awwb?
bevacizumab-awwb (MVASI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for bevacizumab-awwb?
MVASI is a marketed brand name for bevacizumab-awwb. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bevacizumab-awwb?
bevacizumab-awwb has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.